Members Capital Advisors Inc Amgen Inc Transaction History

Members Capital Advisors Inc

  • $86.8 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 19, 2023
SELL
$214.27 - $253.37 $370,044 - $437,569
-1,727 Reduced 27.98%
4,445 $986,000
Q2 2021

Jul 26, 2021
BUY
$233.58 - $259.14 $1.44 Million - $1.6 Million
6,172 New
6,172 $1.5 Million
Q1 2020

May 08, 2020
SELL
$182.24 - $241.7 $1.5 Million - $1.99 Million
-8,241 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$189.21 - $243.2 $1.56 Million - $2 Million
8,241 New
8,241 $1.99 Million

Others Institutions Holding AMGN

# of Institutions
3,123
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Members Capital Advisors Inc Portfolio

Follow Members Capital Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Members Capital Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Members Capital Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email